Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key MetricsGlobeNewsWire • 01/08/26
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026GlobeNewsWire • 12/08/25
Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research • 10/28/25
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 GuidanceGlobeNewsWire • 10/28/25
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025GlobeNewsWire • 10/09/25
Beta Bionics, Inc. (BBNX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/08/25
Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 GuidanceGlobeNewsWire • 07/29/25
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025GlobeNewsWire • 07/02/25
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone SensorGlobeNewsWire • 06/19/25
Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025GlobeNewsWire • 05/06/25
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025GlobeNewsWire • 03/25/25
Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025GlobeNewsWire • 02/27/25
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 01/31/25